# Integrating Computational and Experimental Approaches for the Discovery of Multifunctional Peptides from the Marine Gastropod Pisania pusio with Antimicrobial and Anticancer Properties

**Authors:** Ernesto M. Martell-Huguet, Thalia Moran-Avila, José E. Villuendas, Armando Rodriguez, Ann-Kathrin Kissmann, Ludger Ständker, Sebastian Wiese, Anselmo J. Otero-Gonzalez, Frank Rosenau

PMC · DOI: 10.3390/md24010032 · Marine Drugs · 2026-01-08

## TL;DR

This paper discovers five new peptides from a marine snail that show antimicrobial and anticancer properties, offering potential for drug development.

## Contribution

The study introduces a novel integrated computational and experimental pipeline for identifying multifunctional peptides from marine sources.

## Key findings

- Five novel peptides from Pisania pusio showed antimicrobial activity against multiple bacterial strains.
- Peptide PP1 demonstrated strong anticancer activity against A375 melanoma cells.
- The peptides showed low hemolytic activity and toxicity at high concentrations.

## Abstract

Marine invertebrates are a prime source of biologically active peptides due to their role in humoral immunity. These peptides typically exhibit broad-spectrum functions, including antibacterial, antifungal, anticancer, and immunomodulatory activities. In this report, we describe the identification and biological characterization of five novel bioactive peptides from the marine mollusk Pisania pusio. An extract of P. pusio was analyzed using nanoLC-ESI-MS-MS, and five peptides (PP1–5) were selected via bioinformatic screening as potential antimicrobial and anticancer peptides and subsequently validated experimentally. Among these, PP1, PP2, and PP4 were identified as cryptides derived from the proteolytic cleavage of actin, while PP3 and PP5 are novel peptides with no known protein precursors. All peptides exhibited moderate activity against Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, and Klebsiella pneumoniae with minimum inhibitory concentrations (MICs) predominantly at 100 µM. In contrast, only PP1 and PP5 were active against cancer cells, with PP1 being the most effective against A375 melanoma cells (IC50 = 17.08 µM). This experimental validation confirmed the utility of the integrated in silico/peptidomic pipeline for lead identification. None of these peptides showed significant hemolytic activity or toxicity on fetal lung fibroblasts over 800 μM, demonstrating promising in vitro selectivity. These results highlight the multifunctional nature of P. pusio-derived peptides and their potential as lead compounds for further optimization and development into therapeutic agents against microbial infections and cancer, subject to more comprehensive safety evaluations in relevant models

## Linked entities

- **Proteins:** ACTIN (hypothetical protein)
- **Diseases:** melanoma (MONDO:0005105)
- **Species:** Pisania pusio (taxon 128409), Pseudomonas aeruginosa (taxon 287), Escherichia coli (taxon 562), Staphylococcus aureus (taxon 1280), Klebsiella pneumoniae (taxon 573)

## Full-text entities

- **Diseases:** hemolytic (MESH:D006461), melanoma (MESH:D008545), cancer (MESH:D009369), microbial infections (MESH:D015163), toxicity (MESH:D064420)
- **Chemicals:** PP1 (-), Peptides (MESH:D010455)
- **Species:** Pseudomonas aeruginosa (species) [taxon 287], Klebsiella pneumoniae (species) [taxon 573], Escherichia coli (E. coli, species) [taxon 562], Staphylococcus aureus (species) [taxon 1280], Pisania pusio (miniature trumpet triton, species) [taxon 128409]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12843047/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12843047/full.md

## References

60 references — full list in the complete paper: https://tomesphere.com/paper/PMC12843047/full.md

---
Source: https://tomesphere.com/paper/PMC12843047